Literature DB >> 21812474

Heterogeneous ligand-nanoparticle distributions: a major obstacle to scientific understanding and commercial translation.

Douglas G Mullen1, Mark M Banaszak Holl.   

Abstract

Nanoparticles conjugated with functional ligands are expected to have a major impact in medicine, photonics, sensing, and nanoarchitecture design. One major obstacle to realizing the promise of these materials, however, is the difficulty in controlling the ligand/nanoparticle ratio. This obstacle can be segmented into three key areas: First, many designs of these systems have failed to account for the true heterogeneity of ligand/nanoparticle ratios that compose each material. Second, studies in the field often use the mean ligand/nanoparticle ratio as the accepted level of characterization of these materials. This measure is insufficient because it does not provide information about the distribution of ligand/nanoparticle species within a sample or the number and relative amount of the different species that compose a material. Without these data, researchers do not have an accurate definition of material composition necessary both to understand the material-property relationships and to monitor the consistency of the material. Third, some synthetic approaches now in use may not produce consistent materials because of their sensitivity to reaction kinetics and to the synthetic history of the nanoparticle. In this Account, we describe recent advances that we have made in under standing the material composition of ligand-nanoparticle systems. Our work has been enabled by a model system using poly(amidoamine) dendrimers and two small molecule ligands. Using reverse phase high-pressure liquid chromatography (HPLC), we have successfully resolved and quantified the relative amounts and ratios of each ligand/dendrimer combination. This type of information is rare within the field of ligand-nanoparticle materials because most analytical techniques have been unable to identify the components in the distribution. Our experimental data indicate that the actual distribution of ligand-nanoparticle components is much more heterogeneous than is commonly assumed. The mean ligand/nanoparticle ratio that is typically the only information known about a material is insufficient because the mean does not provide information on the diversity of components in the material and often does not describe the most common component (the mode). Additionally, our experimental data has provided examples of material batches with the same mean ligand/nanoparticle ratio and very different distributions. This discrepancy indicates that the mean cannot be used as the sole metric to assess the reproducibility of a system. We further found that distribution profiles can be highly sensitive to the synthetic history of the starting material as well as slight changes in reaction conditions. We have incorporated the lessons from our experimental data into the design of new ligand-nanoparticle systems to provide improved control over these ratios.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21812474      PMCID: PMC3217083          DOI: 10.1021/ar1001389

Source DB:  PubMed          Journal:  Acc Chem Res        ISSN: 0001-4842            Impact factor:   22.384


  24 in total

1.  The binding avidity of a nanoparticle-based multivalent targeted drug delivery platform.

Authors:  Seungpyo Hong; Pascale R Leroueil; István J Majoros; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Chem Biol       Date:  2007-01

2.  Multifunctionalization of dendrimers through orthogonal transformations.

Authors:  Poorva Goyal; Kunsang Yoon; Marcus Weck
Journal:  Chemistry       Date:  2007       Impact factor: 5.236

3.  Monofunctionalization of dendrimers with use of microwave-assisted 1,3-dipolar cycloadditions.

Authors:  Kunsang Yoon; Poorva Goyal; Marcus Weck
Journal:  Org Lett       Date:  2007-05-02       Impact factor: 6.005

4.  Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.

Authors:  Su-Tang Lo; Stephan Stern; Jeffrey D Clogston; Jiwen Zheng; Pavan P Adiseshaiah; Marina Dobrovolskaia; Jongdoo Lim; Anil K Patri; Xiankai Sun; Eric E Simanek
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

5.  Isolation and characterization of dendrimers with precise numbers of functional groups.

Authors:  Douglas G Mullen; Emilee L Borgmeier; Ankur M Desai; Mallory A van Dongen; Mark Barash; Xue-min Cheng; James R Baker; Mark M Banaszak Holl
Journal:  Chemistry       Date:  2010-09-17       Impact factor: 5.236

6.  Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer.

Authors:  Jolanta F Kukowska-Latallo; Kimberly A Candido; Zhengyi Cao; Shraddha S Nigavekar; Istvan J Majoros; Thommey P Thomas; Lajos P Balogh; Mohamed K Khan; James R Baker
Journal:  Cancer Res       Date:  2005-06-15       Impact factor: 12.701

7.  A quantitative assessment of nanoparticle-ligand distributions: implications for targeted drug and imaging delivery in dendrimer conjugates.

Authors:  Douglas G Mullen; Ming Fang; Ankur Desai; James R Baker; Bradford G Orr; Mark M Banaszak Holl
Journal:  ACS Nano       Date:  2010-02-23       Impact factor: 15.881

8.  Discrete functional gold nanoparticles: hydrogen bond-assisted synthesis, magnetic purification, supramolecular dimer and trimer formation.

Authors:  Chun-Pong Chak; Shouhu Xuan; Paula M Mendes; Jimmy C Yu; Christopher H K Cheng; Ken Cham-Fai Leung
Journal:  ACS Nano       Date:  2009-08-25       Impact factor: 15.881

9.  Nanoparticle-based bio-barcode assay redefines "undetectable" PSA and biochemical recurrence after radical prostatectomy.

Authors:  C Shad Thaxton; Robert Elghanian; Audrey D Thomas; Savka I Stoeva; Jae-Seung Lee; Norm D Smith; Anthony J Schaeffer; Helmut Klocker; Wolfgang Horninger; Georg Bartsch; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2009-10-19       Impact factor: 11.205

Review 10.  Nanocarriers as an emerging platform for cancer therapy.

Authors:  Dan Peer; Jeffrey M Karp; Seungpyo Hong; Omid C Farokhzad; Rimona Margalit; Robert Langer
Journal:  Nat Nanotechnol       Date:  2007-12       Impact factor: 39.213

View more
  21 in total

Review 1.  Dendrimer nanoscaffolds for potential theranostics of prostate cancer with a focus on radiochemistry.

Authors:  Su-Tang Lo; Amit Kumar; Jer-Tsong Hsieh; Xiankai Sun
Journal:  Mol Pharm       Date:  2013-01-24       Impact factor: 4.939

2.  Fluorochrome-functionalized nanoparticles for imaging DNA in biological systems.

Authors:  Hoonsung Cho; David Alcantara; Hushan Yuan; Rahul A Sheth; Howard H Chen; Peng Huang; Sean B Andersson; David E Sosnovik; Umar Mahmood; Lee Josephson
Journal:  ACS Nano       Date:  2013-02-07       Impact factor: 15.881

3.  The nature and implications of uniformity in the hierarchical organization of nanomaterials.

Authors:  Matthew N O'Brien; Matthew R Jones; Chad A Mirkin
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-26       Impact factor: 11.205

4.  Fluorophore:dendrimer ratio impacts cellular uptake and intracellular fluorescence lifetime.

Authors:  Casey A Dougherty; Sriram Vaidyanathan; Bradford G Orr; Mark M Banaszak Holl
Journal:  Bioconjug Chem       Date:  2015-02-05       Impact factor: 4.774

5.  Isolation and characterization of precise dye/dendrimer ratios.

Authors:  Casey A Dougherty; Joseph C Furgal; Mallory A van Dongen; Theodore Goodson; Mark M Banaszak Holl; Janet Manono; Stassi DiMaggio
Journal:  Chemistry       Date:  2014-03-06       Impact factor: 5.236

6.  Zwitterion and Oligo(ethylene glycol) Synergy Minimizes Nonspecific Binding of Compact Quantum Dots.

Authors:  Zhiyuan Han; Suresh Sarkar; Andrew M Smith
Journal:  ACS Nano       Date:  2020-03-11       Impact factor: 15.881

7.  Quantitative analysis of generation and branch defects in G5 poly(amidoamine) dendrimer.

Authors:  Mallory A van Dongen; Ankur Desai; Bradford G Orr; James R Baker; Mark M Banaszak Holl
Journal:  Polymer (Guildf)       Date:  2013-07-19       Impact factor: 4.430

8.  PAMAM Dendrimers as Quantized Building Blocks for Novel Nanostructures.

Authors:  Mallory A van Dongen; S Vaidyanathan; Mark M Banaszak Holl
Journal:  Soft Matter       Date:  2013-12-21       Impact factor: 3.679

9.  Dendrimers terminated with dichlorotriazine groups provide a route to compositional diversity.

Authors:  Subrata Patra; Brittany Kozura; Adela Y-T Huang; Alan E Enciso; Xiankai Sun; Jer-Tsong Hsieh; Chai-Lin Kao; Hui-Ting Chen; Eric E Simanek
Journal:  Org Lett       Date:  2013-07-19       Impact factor: 6.005

10.  Generation 3 PAMAM dendrimer TAMRA conjugates containing precise dye/dendrimer ratios.

Authors:  Janet Manono; Casey A Dougherty; Kirsten Jones; Joshua DeMuth; Mark M Banaszak Holl; Stassi DiMaggio
Journal:  Mater Today (Kidlington)       Date:  2015-06-09       Impact factor: 31.041

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.